{"id":5953,"date":"2017-04-29T08:26:03","date_gmt":"2017-04-29T12:26:03","guid":{"rendered":"https:\/\/digital.hbs.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/"},"modified":"2017-04-29T11:30:24","modified_gmt":"2017-04-29T15:30:24","slug":"using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive","status":"publish","type":"hck-submission","link":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/","title":{"rendered":"Using AR to treat Depression and Alzheimer\u2019s Disease?: Akili Interactive"},"content":{"rendered":"<p><u><\/u><strong>What is Akili Interactive?<\/strong><\/p>\n<p>Akili Interactive is a digital medicines company developing cognitive treatments and assessments through a video game interface.\u00a0 As an augmented reality platform, Akili uses its technology based on cognitive science to treat neurological conditions.\u00a0 Akili\u2019s first product, Evo is currently in clinical trials for ADHD and seeking FDA approval. Akili is also exploring applications of its technology in a number of conditions including Alzheimer\u2019s disease, depression and autism.<\/p>\n<p>Akili is funded by some of the top biopharma and biopharma VCs including Pfizer, Shire, Merck Ventures and Amgen Ventures. Akili was founded in 2011 and has raised a total of $72.9M, including $42.4M in their Series B round in July 2016. <strong><a href=\"https:\/\/www.crunchbase.com\/organization\/akili#\/entity]\">[1]<\/a><\/strong><\/p>\n<p><em>Project Evo<\/em><\/p>\n<p>Akili\u2019s main therapeutic video game, called Project Evo is used to keep track of a user\u2019s movements. The game was designed by Dr. Adam Gazzaley, at the University of California, San Francisco to improve executive function. To play the game, a user navigates an alien avatar on\u00a0a course by tilting a mobile device forwards and back and responds to targets the alien faces by tapping the screen. The game is dynamic and tracks real-time performance so that the game adapts difficulty based on how the player is performing. <strong>[<a href=\"http:\/\/www.mobihealthnews.com\/content\/akili-interactive-labs-raises-another-12m-cognitive-health-game\">2<\/a>]<\/strong><\/p>\n<p><strong><iframe loading=\"lazy\" title=\"Next in Tech: Games to Help ADHD\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/yMBDosb7d18?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\u00a0<\/strong><\/p>\n<p><strong>Valuation Creation<\/strong><\/p>\n<p>By using augmented reality technology, Akili is providing a non-pharmacological treatment to patients suffering from neurological conditions. The company is in clinical trials for ADHD, which the founder and CEO Eddie Martucci predicts will receive FDA approval by end of this year. <a href=\"http:\/\/www.mobihealthnews.com\/content\/akili-interactive-labs-raises-another-12m-cognitive-health-game\"><strong>[3]<\/strong><\/a> The trial, called STARS-ADHD is recruiting non-treated ADHD diagnosed children to play the game, measuring outcomes related to attention and impulsivity. <a href=\"http:\/\/www.mobihealthnews.com\/content\/akili-interactive-labs-launch-adhd-clinical-trial-eye-fda-clearance\"><strong>[4]<\/strong><\/a>\u00a0Akili also partnered in 2014 with Pfizer to study impact of the game on Alzheimer\u2019s disease, and partnered with Duke to run trials in ADHD and autism. Most recently, a number of published articles demonstrated Project: Evo game\u2019s efficacy in improving focus, mood and attention compared to behavioral therapy. \u00a0<strong><a href=\"http:\/\/hsnewsbeat.uw.edu\/story\/studies-suggest-gaming-your-brain-treat-depression\">[5]<\/a><\/strong><\/p>\n<p>The ability for a non-pharmaological treatment to treat conditions like ADHD can be a huge benefit, especially for children who often experience symptoms related to medications like Ritalin and Adderall, such as loss of appetite, insomnia and increased blood pressure and heart rate.<\/p>\n<p><strong>Value Capture<\/strong><\/p>\n<p>If Akili\u2019s product is approved, it would be the first video game to be approved by the FDA for a therapeutic treatment.\u00a0 The reimbursement of this drug is hinged on approval. It is likely payments will probably be comparable or markedly less than current ADHD drugs on the market including Ritalin. Based on the formulary tier an ADHD drug is designated, an ADHD drug can cost anywhere from $15\/month for a generic to $200-300\/month for brand name drugs like Adderall and Ritalin <a href=\"http:\/\/consumerhealthchoices.org\/wp-content\/uploads\/2012\/08\/BBD-ADHD-Full.pdf\">[6]<\/a>. \u00a0I would recommend a subscription value capture\u00a0model so the\u00a0company can establish a\u00a0steady stream of revenue. \u00a0I would also price it at a roughly 50% discount to brand name drugs, assuming similar if not superior efficacy. It is likely this non-therapeutic treatment will be seen not as a replacement for pharmacological treatments but as an additive therapy to the drugs or a way to decrease current drug dosage of ADHD children&#8217;s prescriptions.<\/p>\n<p><strong>Recommendations to Grow<\/strong><\/p>\n<p>The applications for Akili\u2019s software is enormous for the treatment of neurological conditions. Clinical approval of a treatment has a much higher risk but also a higher reward profile for Akili. As the first possible non-pharmacological treatment for ADHD, the success of the company hinges not only on results that the technology improves both primary and secondary ADHD endpoints, but also that health plans will pay for it. An important decision\u00a0the company will have to think about if the clinical strategy is not successful is whether there is merit to pivot and market this product direct-to-consumers as an educational tool. \u00a0On the other hand, the education and marketing investments required of a consumer company would differ extensively from Akili\u2019s clinical product.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Akili Interactive using AR technology to treat Alzheimer&#8217;s Disease, Depression and ADHD<\/p>\n","protected":false},"author":1199,"featured_media":6064,"comment_status":"open","ping_status":"closed","template":"","categories":[1526,1523,1519,1518,1460,1524,748,1522,1525,1520,1521],"class_list":["post-5953","hck-submission","type-hck-submission","status-publish","has-post-thumbnail","hentry","category-adderall","category-adhd","category-akili-interactive","category-alzheimers-disease","category-augmented-reality","category-autism","category-biopharma","category-depression","category-ritalin","category-therapeutic","category-video-game"],"connected_submission_link":"https:\/\/d3.harvard.edu\/platform-digit\/assignment\/what-is-the-future-of-vr\/","yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Using AR to treat Depression and Alzheimer\u2019s Disease?: Akili Interactive - Digital Innovation and Transformation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Using AR to treat Depression and Alzheimer\u2019s Disease?: Akili Interactive - Digital Innovation and Transformation\" \/>\n<meta property=\"og:description\" content=\"Akili Interactive using AR technology to treat Alzheimer&#039;s Disease, Depression and ADHD\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/\" \/>\n<meta property=\"og:site_name\" content=\"Digital Innovation and Transformation\" \/>\n<meta property=\"article:modified_time\" content=\"2017-04-29T15:30:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2017\/04\/Akili_Logo_simple.png\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"163\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\\\/\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\\\/\",\"name\":\"Using AR to treat Depression and Alzheimer\u2019s Disease?: Akili Interactive - Digital Innovation and Transformation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/04\\\/Akili_Logo_simple.png\",\"datePublished\":\"2017-04-29T12:26:03+00:00\",\"dateModified\":\"2017-04-29T15:30:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\\\/#primaryimage\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/04\\\/Akili_Logo_simple.png\",\"contentUrl\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/04\\\/Akili_Logo_simple.png\",\"width\":500,\"height\":163},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Submissions\",\"item\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Using AR to treat Depression and Alzheimer\u2019s Disease?: Akili Interactive\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/#website\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/\",\"name\":\"Digital Innovation and Transformation\",\"description\":\"MBA Student Perspectives\",\"potentialAction\":[{\"@type\":\"性视界Action\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Using AR to treat Depression and Alzheimer\u2019s Disease?: Akili Interactive - Digital Innovation and Transformation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/","og_locale":"en_US","og_type":"article","og_title":"Using AR to treat Depression and Alzheimer\u2019s Disease?: Akili Interactive - Digital Innovation and Transformation","og_description":"Akili Interactive using AR technology to treat Alzheimer's Disease, Depression and ADHD","og_url":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/","og_site_name":"Digital Innovation and Transformation","article_modified_time":"2017-04-29T15:30:24+00:00","og_image":[{"width":500,"height":163,"url":"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2017\/04\/Akili_Logo_simple.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/","url":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/","name":"Using AR to treat Depression and Alzheimer\u2019s Disease?: Akili Interactive - Digital Innovation and Transformation","isPartOf":{"@id":"https:\/\/d3.harvard.edu\/platform-digit\/#website"},"primaryImageOfPage":{"@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/#primaryimage"},"image":{"@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/#primaryimage"},"thumbnailUrl":"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2017\/04\/Akili_Logo_simple.png","datePublished":"2017-04-29T12:26:03+00:00","dateModified":"2017-04-29T15:30:24+00:00","breadcrumb":{"@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/#primaryimage","url":"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2017\/04\/Akili_Logo_simple.png","contentUrl":"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2017\/04\/Akili_Logo_simple.png","width":500,"height":163},{"@type":"BreadcrumbList","@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/using-ar-to-treat-depression-and-alzheimers-disease-akili-interactive\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d3.harvard.edu\/platform-digit\/"},{"@type":"ListItem","position":2,"name":"Submissions","item":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/"},{"@type":"ListItem","position":3,"name":"Using AR to treat Depression and Alzheimer\u2019s Disease?: Akili Interactive"}]},{"@type":"WebSite","@id":"https:\/\/d3.harvard.edu\/platform-digit\/#website","url":"https:\/\/d3.harvard.edu\/platform-digit\/","name":"Digital Innovation and Transformation","description":"MBA Student Perspectives","potentialAction":[{"@type":"性视界Action","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d3.harvard.edu\/platform-digit\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/hck-submission\/5953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/hck-submission"}],"about":[{"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/types\/hck-submission"}],"author":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/users\/1199"}],"replies":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/comments?post=5953"}],"version-history":[{"count":0,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/hck-submission\/5953\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/media\/6064"}],"wp:attachment":[{"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/media?parent=5953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/categories?post=5953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}